Tumour model

A2780

XenograftIn vitro

A2780 cells

Human A2780 cells were isolated from a patient with ovarian endometrioid adenocarcinoma.

Tumour growth in vivo

The cells were collected from a tissue culture flask and injected subcutaneously in the right flank of SCID-CB17 mice. The resulting tumours were monitored by measuring two diameters with calipers, and extrapolating the volume to a sphere.
The mice bearing A2780 tumours can be treated by intra-peritoneal, intra-venous, intra-tumoral or subcutaneous injection of the compounds. Per os administration is also possible.

Figure 1: (View PDF)
Tumour growth curve of the A2780 cells as xenograft Mean ± SEM (n=3; take rate 100%)

Standard-Of-Care Drug Responses

gemcitabine 120 mg/kg 3x/w from implantation → Response

Figure 2: (View PDF)
Effect of gemcitabine treatment on A2780 tumour growth
Mean ± SEM (n=3 per group; take rate 100%)

Download PDF

Model characteristics

Organism
Human
Tissue of origin
Ovary
Pathology
Model type
In vitro, Xenograft
Availability
2 to 3 weeks

Request this model

Tell us about your compound and your endpoints. Our team confirms feasibility, timelines and study design before any commitment.

Related models

Other models sharing the same tissue of origin.

Model
Organism
Tissue of origin
Pathology
Type
Human
Ovary
Ovarian adenocarcinoma
XenograftIn vitro

ID8

Mouse
Ovary
Epithelial ovarian cancer
SyngeneicIn vitro
Human
Ovary
Malignant Papillary Serous Adenocarcinoma
XenograftIn vitro
Human
Ovary
Primary Malignant Adenocarcinoma; Grade 3, stage IIIC
XenograftIn vitro

KGN

Human
Ovary
Ovarian granulosa cell tumor
XenograftIn vitro
Human
Ovary
High grade ovarian serous adenocarcinoma
XenograftIn vitro